Steroid-induced CT changes in patients with recurrent malignant glioma
- PMID: 3362369
- DOI: 10.1212/wnl.38.5.724
Steroid-induced CT changes in patients with recurrent malignant glioma
Abstract
The magnitude and time course of steroid-induced CT changes were analyzed in 11 patients with recurrent malignant glioma. CTs were obtained before and at regular intervals after starting dexamethasone (16 mg/d). Midline shift, ventricular compression, edema, enhancement intensity, and the size of the enhancing mass often improved with steroid treatment. Improvement occurred within 2 weeks in most instances. Changes in the volume of the enhancing tumor were assessed quantitatively in eight patients. In six, the mass was smaller after 2 weeks of steroid therapy, and in two the reduction approached 50%. Steroid-induced CT changes can mimic treatment responses. If steroids are necessary for symptom control, patients should be taking these medications for 2 weeks before a baseline CT is obtained and investigational treatment started.
Similar articles
-
CT-analyses of cerebral tumors under steroid therapy.Neuroradiology. 1984;26(4):293-8. doi: 10.1007/BF00339773. Neuroradiology. 1984. PMID: 6462436
-
Corticosteroid-induced magnetic resonance imaging changes in patients with recurrent malignant glioma.J Clin Oncol. 1994 Sep;12(9):1886-9. doi: 10.1200/JCO.1994.12.9.1886. J Clin Oncol. 1994. PMID: 8083712
-
[Disappearance of enhancement of brain tumor in contrast CT scan after excessively high dosage of dexamethasone--suggestive indication of steroid administration by CT scan].No Shinkei Geka. 1983 Feb;11(2):157-63. No Shinkei Geka. 1983. PMID: 6843767 Japanese. No abstract available.
-
Effect of dexamethasone treatment on volume and contrast enhancement of intracranial neoplasms.J Comput Assist Tomogr. 1983 Apr;7(2):295-300. doi: 10.1097/00004728-198304000-00017. J Comput Assist Tomogr. 1983. PMID: 6833563
-
Immediate post-radiotherapy changes in malignant glioma can mimic tumor progression.Neurology. 2004 Aug 10;63(3):535-7. doi: 10.1212/01.wnl.0000133398.11870.9a. Neurology. 2004. PMID: 15304589 Review.
Cited by
-
Serial proton MR spectroscopic imaging of recurrent malignant gliomas after gamma knife radiosurgery.AJNR Am J Neuroradiol. 2001 Apr;22(4):613-24. AJNR Am J Neuroradiol. 2001. PMID: 11290467 Free PMC article.
-
Updated Response Assessment in Neuro-Oncology (RANO) for Gliomas.Curr Neurol Neurosci Rep. 2024 Feb;24(2):17-25. doi: 10.1007/s11910-023-01329-4. Epub 2024 Jan 3. Curr Neurol Neurosci Rep. 2024. PMID: 38170429 Review.
-
Response assessment challenges in clinical trials of gliomas.Curr Oncol Rep. 2010 Jan;12(1):68-75. doi: 10.1007/s11912-009-0078-3. Curr Oncol Rep. 2010. PMID: 20425610 Review.
-
MRI and thallium-201 SPECT in the prediction of survival in glioma.Neuroradiology. 2012 Jun;54(6):539-46. doi: 10.1007/s00234-011-0908-5. Epub 2011 Jul 14. Neuroradiology. 2012. PMID: 21755329 Clinical Trial.
-
End point assessment in gliomas: novel treatments limit usefulness of classical Macdonald's Criteria.J Clin Oncol. 2009 Jun 20;27(18):2905-8. doi: 10.1200/JCO.2009.22.4998. Epub 2009 May 18. J Clin Oncol. 2009. PMID: 19451418 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials